Environmentalists are warning that Mexico, the cradle of corn, risks damaging its staple if the government gives US firms the green light to plant genetically-modified maize in huge swaths of land.
Biotechnology
Nov 20, 2012
2
0
The availability of more affordable drugs, vaccines and diagnostics that would help countless people worldwide is the foremost benefit expected from a growing number of collaborations between biotech firms in developing countries, ...
Biotechnology
May 10, 2010
0
0
The pharmaceuticals industry presents a quandary for potential investors: Major investments in drug development pay off handsomely in a relatively small number of cases, but many other projects deliver no returns at all. ...
Biotechnology
Oct 4, 2012
0
0
New York-based pharmaceutical giant Bristol-Myers Squibb on Thursday announced it would buy US biotech firm Celgene in a $74 billion cash-and-stock deal, creating a rival to the world's largest drug makers.
Business
Jan 3, 2019
0
10
Companies searching for cures for cancer and testing treatments for crippling genetic diseases are capturing the interest of venture capitalists - and their money - more than at any time in the last seven years.
Business
May 28, 2015
0
18
In a quiet business park far from Seattle's booming South Lake Union, players in the Northwest's "other" tech sector are coping with growing pains of their own.
Business
Jan 31, 2019
0
6
As 2018 draws to a close, the pharmaceutical industry is celebrating a prosperous year of new investments and therapeutic breakthroughs. These successes were driven by cutting-edge science and progress in finally translating ...
Other
Dec 5, 2018
0
6
It isn't often that you see heavyweights in the tech world duking it out in a high-stakes match, with Congress as the referee. It's happening today over proposed reforms in patent law, which pits the software and information ...
Business
Apr 7, 2009
0
0
The European Commission launched a proposal in July 2023 to deregulate a large number of plants manufactured using new genetic techniques.
Biotechnology
Dec 18, 2023
0
12
The lure of greater profits elsewhere in the world may divert bio-pharmaceutical firms in developing countries from the creation and distribution of affordable drugs, vaccines and diagnostics for illnesses of local concern, ...
Biotechnology
Sep 9, 2010
0
0
